Related Experiment Video
Updated: Sep 30, 2025

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
Published on: June 20, 2014
Cardiovascular Magnetic Resonance Detects Inflammatory Cardiomyopathy in Symptomatic Patients with Inflammatory Joint
George Markousis-Mavrogenis1, Maria Bonou2, Vasiliki Vartela1
1Onassis Cardiac Surgery Center, 17674 Athens, Greece.
Insights
Cardiovascular magnetic resonance (CMR) detects significant cardiac inflammation in patients with inflammatory joint diseases (IJD) who have unexplained symptoms. This imaging technique is valuable for identifying myocardial abnormalities when routine tests are inconclusive.
Area of Science:
- Cardiology
- Rheumatology
- Medical Imaging
Background:
- Patients with inflammatory joint diseases (IJD) face a higher risk of cardiovascular disease.
- Routine clinical evaluations often fail to detect cardiac abnormalities in IJD patients with atypical symptoms.
- Cardiovascular magnetic resonance (CMR) is explored for its potential to identify subclinical cardiac issues in this population.
Purpose of the Study:
- To investigate the utility of CMR in detecting cardiac abnormalities in patients with IJD and unexplained symptoms.
- To compare CMR findings between IJD patients and a control group with similar symptoms but no IJD.
Main Methods:
- 51 IJD patients (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis) with normal baseline cardiac workups underwent CMR.
- 40 non-IJD controls with similar atypical cardiac symptoms were also evaluated using CMR.
- CMR utilized 1.5 T or 3.0 T systems, including T1/T2 mapping and gadolinium enhancement sequences.
Main Results:
- 49% of IJD patients showed replacement-type myocardial fibrosis, compared to 0% in controls (p < 0.001).
- IJD patients exhibited significantly higher T2 signal ratios, gadolinium enhancement, and extracellular volume fractions.
- Native T1 mapping was significantly elevated in IJD patients, irrespective of MRI field strength (p < 0.001).
Conclusions:
- CMR effectively identifies myocardial inflammation in IJD patients with cardiac symptoms discordant with standard evaluations.
- The findings suggest CMR is a valuable tool for assessing cardiac involvement in IJD patients.
- Consideration of CMR is recommended for IJD patients presenting with unexplained cardiac symptoms.
Abstract:
Background. Patients with inflammatory joint diseases (IJD) are more likely to develop cardiovascular disease compared with the general population. We hypothesized that cardiovascular magnetic resonance (CMR) could identify cardiac abnormalities in patients with IJD and atypical symptoms unexplained by routine clinical evaluation. Patients-Methods. A total of 51 consecutive patients with IJD (32 with rheumatoid arthritis, 10 with ankylosing spondylitis, and 9 with psoriatic arthritis) and normal clinical, electrocardiographic and echocardiographic workups, were referred for CMR evaluation due to atypical chest pain, shortness of breath, and/or palpitations. Their CMR findings were compared with those of 40 non-IJD controls who were referred for the same reason. All participants were examined using either a 1.5 T or 3.0 T CMR system. For T1/T2 mapping, comparisons were performed separately for each field strength. Results. Biventricular systolic function was similar between groups. In total, 25 (49%) patients with IJD vs. 0 (0%) controls had replacement-type myocardial fibrosis (p < 0.001). The T2 signal ratio, early/late gadolinium enhancement, and extracellular volume fraction were significantly higher in the IJD group. Native T1 mapping was significantly higher in patients with IJD independent of the MRI field strength (p < 0.001 for both). T2 mapping was significantly higher in patients with IJD compared with controls only in those examined using a 1.5 T MR system—52.0 (50.0, 55.0) vs. 37.0 (33.5, 39.5), p < 0.001. Conclusions. In patients with IJD and a mismatch between cardiac symptoms and routine non-invasive evaluation, CMR uniquely identified a significant proportion of patients with myocardial inflammation. A CMR examination should be considered in patients with IJD in similar clinical settings.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Imaging Studies for Cardiovascular System IV: CMRI
Myocarditis II: Clinical Features and Diagnostic Tests
Cardiomyopathy IV: Restrictive Cardiomyopathy
Pericarditis II: Clinical Features and Diagnostic Tests
Rheumatic Heart Disease I: Introduction

